KYORIN Pharmaceutical Co., Ltd. (KYRNF)
10.31
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
KYORIN Pharmaceutical Total Assets (Quarterly) : 1.229B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 97.13B |
| Daiichi Sankyo Co., Ltd. | 25.18B |
| Eisai Co., Ltd. | 9.109B |
| Chugai Pharmaceutical Co., Ltd. | 14.24B |
| Santen Pharmaceutical Co., Ltd. | 2.659B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 333.30M |
| Shareholders Equity (Quarterly) | 895.25M |
| Debt to Equity Ratio | 0.167 |
| Current Ratio | 4.602 |
| Net Debt Paydown Yield | 1.95% |